首页 > 最新文献

Frontiers in reproductive health最新文献

英文 中文
Corrigendum: How might we motivate uptake of the Dual Prevention Pill? Findings from human-centered design research with potential end users, male partners, and healthcare providers. 更正:我们该如何激励人们使用双重预防药丸?与潜在最终用户、男性伴侣和医疗服务提供者进行的以人为本的设计研究结果。
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-12-05 eCollection Date: 2023-01-01 DOI: 10.3389/frph.2023.1341771
Wawira Nyagah, Kate Segal, Jess Feltham, Alex Ash, Jocelyn Major, Moowa Masani

[This corrects the article DOI: 10.3389/frph.2023.1254953.].

[此处更正了文章 DOI:10.3389/frph.2023.1254953]。
{"title":"Corrigendum: How might we motivate uptake of the Dual Prevention Pill? Findings from human-centered design research with potential end users, male partners, and healthcare providers.","authors":"Wawira Nyagah, Kate Segal, Jess Feltham, Alex Ash, Jocelyn Major, Moowa Masani","doi":"10.3389/frph.2023.1341771","DOIUrl":"https://doi.org/10.3389/frph.2023.1341771","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/frph.2023.1254953.].</p>","PeriodicalId":73103,"journal":{"name":"Frontiers in reproductive health","volume":"5 ","pages":"1341771"},"PeriodicalIF":0.0,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138814498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual, reproductive and mental health among young men (10–24) in low-and-middle income countries: a scoping review 中低收入国家年轻男性(10-24 岁)的性健康、生殖健康和心理健康:范围界定审查
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-12-04 DOI: 10.3389/frph.2023.1119407
Siphiwe Mhlongo, A. Mason-Jones, Keith Ford
The relationship between SRH and mental health among men is not well documented, especially in the 10–24 age group. This scoping review aimed to investigate what is known about the association between SRH and mental health among young men (10–24) in LMICs.Embase, APA PsycInfo, MEDLINE(R) ALL, ASSIA and the Cochrane Library of Database of Systematic Reviews were searched from the year of establishment up to August 2022. The review was reported using the PRISMA-ScR checklist.A total of (n = 2636) studies were identified from the five databases. After the completion of screening, only ten studies (n = 8 cross-sectional, n = 1 mixed methods and n = 1 qualitative) met the eligibility criteria and were included in the review. The findings suggest that there is a reciprocal relationship between mental health and SRH. Sperm concentration and total sperm count were found to be lower in depressed men. Poor mental health was associated with early sexual debut, higher rates of sexual activity and an increased number of sexual partners. Poor mental health was also found among men who had sex with men (MSM). In addition, we found a relationship between sexual abuse, sexual coercion and poor mental health.The findings of this unique study indicate that poor mental health is associated with poor SRH outcomes and vice versa among young men (10–24) living in LMICs. However, further research will be needed to establish the temporal relationship between SRH and mental health outcomes.
性健康生殖健康与男性心理健康之间的关系,特别是10-24岁年龄组之间的关系,没有很好的文献记载。本综述旨在调查中低收入国家年轻男性(10-24岁)的性生殖健康与心理健康之间已知的关联。检索了Embase、APA PsycInfo、MEDLINE(R) ALL、ASSIA和Cochrane系统评价数据库库,检索时间从建库年至2022年8月。使用PRISMA-ScR检查表进行回顾报告。从五个数据库中共确定了(n = 2636)项研究。筛选完成后,只有10项研究(n = 8横断面法、n = 1混合法和n = 1定性法)符合入选标准,纳入本综述。研究结果表明,心理健康与性健康和生殖健康之间存在相互关系。研究发现,抑郁男性的精子浓度和精子总数较低。较差的心理健康状况与较早的初次性行为、较高的性活动率和更多的性伴侣有关。男男性行为者(MSM)的心理健康状况也不佳。此外,我们还发现了性虐待、性胁迫与心理健康状况不佳之间的关系。这项独特研究的结果表明,生活在低收入中低收入国家的年轻男性(10-24岁)心理健康状况不佳与性生殖健康状况不佳相关,反之亦然。然而,需要进一步的研究来确定性生殖健康与心理健康结果之间的时间关系。
{"title":"Sexual, reproductive and mental health among young men (10–24) in low-and-middle income countries: a scoping review","authors":"Siphiwe Mhlongo, A. Mason-Jones, Keith Ford","doi":"10.3389/frph.2023.1119407","DOIUrl":"https://doi.org/10.3389/frph.2023.1119407","url":null,"abstract":"The relationship between SRH and mental health among men is not well documented, especially in the 10–24 age group. This scoping review aimed to investigate what is known about the association between SRH and mental health among young men (10–24) in LMICs.Embase, APA PsycInfo, MEDLINE(R) ALL, ASSIA and the Cochrane Library of Database of Systematic Reviews were searched from the year of establishment up to August 2022. The review was reported using the PRISMA-ScR checklist.A total of (n = 2636) studies were identified from the five databases. After the completion of screening, only ten studies (n = 8 cross-sectional, n = 1 mixed methods and n = 1 qualitative) met the eligibility criteria and were included in the review. The findings suggest that there is a reciprocal relationship between mental health and SRH. Sperm concentration and total sperm count were found to be lower in depressed men. Poor mental health was associated with early sexual debut, higher rates of sexual activity and an increased number of sexual partners. Poor mental health was also found among men who had sex with men (MSM). In addition, we found a relationship between sexual abuse, sexual coercion and poor mental health.The findings of this unique study indicate that poor mental health is associated with poor SRH outcomes and vice versa among young men (10–24) living in LMICs. However, further research will be needed to establish the temporal relationship between SRH and mental health outcomes.","PeriodicalId":73103,"journal":{"name":"Frontiers in reproductive health","volume":"9 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138602937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Qualitative perspectives on COVID-19, interpersonal violence, and interventions to improve well-being from adolescent girls and young women in Kisumu, Kenya 肯尼亚基苏木少女和年轻妇女对 COVID-19、人际暴力以及改善福祉的干预措施的定性看法
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-12-01 DOI: 10.3389/frph.2023.1236588
Ruby E. Reed, Mevis Omollo, I. Odero, Eucabeth Awuonda, Peter Ochere, Ken Ondeng’e, Jennifer L Kang, Jonathan Altamirano, H. Barsosio, C. Sarnquist
Adolescent girls and young women (AGYW) face a high burden of gender-based violence (GBV) worldwide. The COVID-19 pandemic and associated policies led to global increases in GBV, decreased access to resources, and disruptions of pathways to care. We aimed to understand the effects of COVID-19 on AGYW affected by GBV in Kisumu, Kenya, as well as to identify possible interventions to mitigate those effects.Focus group discussions (FGDs) were conducted with AGYW aged 15–25 with a history of exposure to GBV. AGYW were split into age-matched groups; aged 15–19 for younger groups and 19–25 for older groups. Discussions focused on how COVID-19 affected experiences of GBV, access to care services, economic and social outcomes, and opportunities for interventions to mitigate negative impacts of COVID-19 and violence.Five FGDs with 46 AGYW were completed in June-September 2021. AGYW described increases in all types of GBV, particularly sexual abuse and intimate partner violence. Early marriage and subsistence transactional sex also increased. AGYW described violence as both a cause and effect of poor economic, social and health consequences related to the pandemic. Notably, AGYW emphasized stress, lack of mental health support and increased substance use as risk factors for violence, and discussed the deleterious mental health effects of violence—particularly in the wake of disruption of mental health services. COVID-19 disrupted referrals to violence-related services, and reduced access to both medical services and psychosocial services. AGYW believed that interventions focused on improving mental health as well as economic empowerment would be the most feasible and acceptable in mitigating the negative effects of COVID-19 and related exacerbations in violence.AGYW reported increases in almost all forms of GBV during the pandemic, with related exacerbation in mental health. Concurrently, AGYW endorsed decreased access to care services. As there is no evidence that violence and mental health challenges will quickly resolve, there is an urgent need to identify and implement interventions to mitigate these negative effects.
在世界范围内,少女和年轻妇女面临着性别暴力的沉重负担。2019冠状病毒病大流行和相关政策导致全球性别暴力增加,资源获取减少,医疗途径中断。我们的目的是了解COVID-19对肯尼亚基苏木受性别暴力影响的AGYW的影响,并确定可能的干预措施来减轻这些影响。对有GBV暴露史的15-25岁AGYW进行焦点小组讨论(fgd)。AGYW被分为年龄匹配组;青少年为15-19岁,老年人为19-25岁。讨论的重点是COVID-19如何影响性别暴力的经历、获得护理服务的机会、经济和社会结果,以及采取干预措施减轻COVID-19和暴力的负面影响的机会。2021年6月至9月完成了5艘fgd和46艘AGYW。AGYW描述了所有类型的性别暴力的增加,特别是性虐待和亲密伴侣暴力。早婚和维持生计的性交易也有所增加。妇女与妇女联合会认为,暴力既是与这一流行病有关的不良经济、社会和健康后果的原因,也是后果。值得注意的是,AGYW强调压力、缺乏精神健康支持和药物使用增加是暴力的风险因素,并讨论了暴力对精神健康的有害影响,特别是在精神健康服务中断之后。COVID-19中断了向暴力相关服务的转诊,减少了获得医疗服务和社会心理服务的机会。世界妇女大会认为,在减轻COVID-19的负面影响和相关暴力加剧方面,以改善心理健康和增强经济权能为重点的干预措施是最可行和最可接受的。据AGYW报告,在大流行期间,几乎所有形式的性别暴力都有所增加,心理健康状况也随之恶化。同时,AGYW赞同减少获得护理服务的机会。由于没有证据表明暴力和心理健康挑战将迅速得到解决,因此迫切需要确定和实施干预措施,以减轻这些负面影响。
{"title":"Qualitative perspectives on COVID-19, interpersonal violence, and interventions to improve well-being from adolescent girls and young women in Kisumu, Kenya","authors":"Ruby E. Reed, Mevis Omollo, I. Odero, Eucabeth Awuonda, Peter Ochere, Ken Ondeng’e, Jennifer L Kang, Jonathan Altamirano, H. Barsosio, C. Sarnquist","doi":"10.3389/frph.2023.1236588","DOIUrl":"https://doi.org/10.3389/frph.2023.1236588","url":null,"abstract":"Adolescent girls and young women (AGYW) face a high burden of gender-based violence (GBV) worldwide. The COVID-19 pandemic and associated policies led to global increases in GBV, decreased access to resources, and disruptions of pathways to care. We aimed to understand the effects of COVID-19 on AGYW affected by GBV in Kisumu, Kenya, as well as to identify possible interventions to mitigate those effects.Focus group discussions (FGDs) were conducted with AGYW aged 15–25 with a history of exposure to GBV. AGYW were split into age-matched groups; aged 15–19 for younger groups and 19–25 for older groups. Discussions focused on how COVID-19 affected experiences of GBV, access to care services, economic and social outcomes, and opportunities for interventions to mitigate negative impacts of COVID-19 and violence.Five FGDs with 46 AGYW were completed in June-September 2021. AGYW described increases in all types of GBV, particularly sexual abuse and intimate partner violence. Early marriage and subsistence transactional sex also increased. AGYW described violence as both a cause and effect of poor economic, social and health consequences related to the pandemic. Notably, AGYW emphasized stress, lack of mental health support and increased substance use as risk factors for violence, and discussed the deleterious mental health effects of violence—particularly in the wake of disruption of mental health services. COVID-19 disrupted referrals to violence-related services, and reduced access to both medical services and psychosocial services. AGYW believed that interventions focused on improving mental health as well as economic empowerment would be the most feasible and acceptable in mitigating the negative effects of COVID-19 and related exacerbations in violence.AGYW reported increases in almost all forms of GBV during the pandemic, with related exacerbation in mental health. Concurrently, AGYW endorsed decreased access to care services. As there is no evidence that violence and mental health challenges will quickly resolve, there is an urgent need to identify and implement interventions to mitigate these negative effects.","PeriodicalId":73103,"journal":{"name":"Frontiers in reproductive health","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138621922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standardized protocol for quantification of nerve bundle density as a biomarker for endometriosis. 作为子宫内膜异位症生物标志物的神经束密度量化标准化方案。
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-30 eCollection Date: 2023-01-01 DOI: 10.3389/frph.2023.1297986
Gerbrand Zoet, Dwayne R Tucker, Natasha L Orr, Fahad T Alotaibi, Yang Doris Liu, Heather Noga, Martin Köbel, Paul J Yong

Introduction: We propose a standardized protocol for measurement of nerve bundle density in endometriosis as a potential biomarker, including in deep endometriosis (DE), ovarian endometriomas (OMA) and superficial peritoneal endometriosis (SUP).

Methods: This was a prospective cohort of surgically excised endometriosis samples from Dec 1st 2013 and Dec 31st 2017 at a tertiary referral center for endometriosis in Vancouver, BC, Canada. Surgical data were available from linked patient registry. Protein gene product 9.5 (PGP9.5) was used to identify nerve bundles on immunohistochemistry. PGP9.5 nerve bundles were counted visually. To calculate nerve bundle density, PGP9.5 nerve bundle count was divided by the tissue surface area (total on the slide). All samples were assessed using NHS Elements software for semi-automated measurement of the tissue surface area. For a subset of samples, high power fields (HPFs) were also counted as manual measurement of the tissue surface area. Intraclass correlation was used to assess intra observer and inter observer reliability. Generalized linear mixed model (GLMM) with random intercepts only was conducted to assess differences in PGP9.5 nerve bundle density by endometriosis type (DE, OMA, SUP).

Results: In total, 236 tissue samples out of 121 participants were available for analysis in the current study. Semi-automated surface area measurement could be performed in 94.5% of the samples and showed good correlation with manually counted HPFs (Spearman's rho = 0.781, p < 0.001). To assess intra observer reliability, 11 samples were assessed twice by the same observer; to assess inter observer reliability, 11 random samples were blindly assessed by two observers. Intra observer reliability and inter observer reliability for nerve bundle density were excellent: 0.979 and 0.985, respectively. PGP9.5 nerve bundle density varied among samples and no nerve bundles could be found in 24.6% of the samples. GLMM showed a significant difference in PGP9.5 nerve bundle density between the different endometriosis types (X2 = 87.6, P < 0.001 after adjusting for hormonal therapy, with higher density in DE and SUP in comparison to OMA).

Conclusion: A standardized protocol is presented to measure PGP9.5 nerve bundle density in endometriosis, which may serve as a biomarker reflecting local neurogenesis in the endometriosis microenvironment.

导言:我们提出了一种测量子宫内膜异位症神经束密度的标准化方案,将其作为一种潜在的生物标志物,包括深部子宫内膜异位症(DE)、卵巢子宫内膜异位症(OMA)和浅表腹膜子宫内膜异位症(SUP):这是一项前瞻性队列研究,研究对象是加拿大不列颠哥伦比亚省温哥华市一家子宫内膜异位症三级转诊中心从2013年12月1日至2017年12月31日期间手术切除的子宫内膜异位症样本。手术数据可从链接的患者登记处获得。蛋白基因产物9.5(PGP9.5)用于通过免疫组化鉴定神经束。肉眼计数PGP9.5神经束。计算神经束密度时,PGP9.5神经束计数除以组织表面积(载玻片上的总面积)。所有样本均使用 NHS Elements 软件进行评估,以半自动测量组织表面积。对于一部分样本,高倍视野(HPF)也被计算在内,作为组织表面积的人工测量。类内相关性用于评估观察者内部和观察者之间的可靠性。仅使用随机截距的广义线性混合模型(GLMM)来评估子宫内膜异位症类型(DE、OMA、SUP)在 PGP9.5 神经束密度方面的差异:本研究共采集了 121 名参与者的 236 份组织样本进行分析。94.5%的样本可进行半自动表面积测量,并与人工计数的 HPFs 显示出良好的相关性(Spearman's rho = 0.781,P 2 = 87.6,P 结论:本文介绍了测量子宫内膜异位症中PGP9.5神经束密度的标准化方案,该方案可作为反映子宫内膜异位症微环境中局部神经发生的生物标志物。
{"title":"Standardized protocol for quantification of nerve bundle density as a biomarker for endometriosis.","authors":"Gerbrand Zoet, Dwayne R Tucker, Natasha L Orr, Fahad T Alotaibi, Yang Doris Liu, Heather Noga, Martin Köbel, Paul J Yong","doi":"10.3389/frph.2023.1297986","DOIUrl":"https://doi.org/10.3389/frph.2023.1297986","url":null,"abstract":"<p><strong>Introduction: </strong>We propose a standardized protocol for measurement of nerve bundle density in endometriosis as a potential biomarker, including in deep endometriosis (DE), ovarian endometriomas (OMA) and superficial peritoneal endometriosis (SUP).</p><p><strong>Methods: </strong>This was a prospective cohort of surgically excised endometriosis samples from Dec 1st 2013 and Dec 31st 2017 at a tertiary referral center for endometriosis in Vancouver, BC, Canada. Surgical data were available from linked patient registry. Protein gene product 9.5 (PGP9.5) was used to identify nerve bundles on immunohistochemistry. PGP9.5 nerve bundles were counted visually. To calculate nerve bundle density, PGP9.5 nerve bundle count was divided by the tissue surface area (total on the slide). All samples were assessed using NHS Elements software for semi-automated measurement of the tissue surface area. For a subset of samples, high power fields (HPFs) were also counted as manual measurement of the tissue surface area. Intraclass correlation was used to assess intra observer and inter observer reliability. Generalized linear mixed model (GLMM) with random intercepts only was conducted to assess differences in PGP9.5 nerve bundle density by endometriosis type (DE, OMA, SUP).</p><p><strong>Results: </strong>In total, 236 tissue samples out of 121 participants were available for analysis in the current study. Semi-automated surface area measurement could be performed in 94.5% of the samples and showed good correlation with manually counted HPFs (Spearman's rho = 0.781, <i>p</i> < 0.001). To assess intra observer reliability, 11 samples were assessed twice by the same observer; to assess inter observer reliability, 11 random samples were blindly assessed by two observers. Intra observer reliability and inter observer reliability for nerve bundle density were excellent: 0.979 and 0.985, respectively. PGP9.5 nerve bundle density varied among samples and no nerve bundles could be found in 24.6% of the samples. GLMM showed a significant difference in PGP9.5 nerve bundle density between the different endometriosis types (X<sup>2</sup> = 87.6, <i>P</i> < 0.001 after adjusting for hormonal therapy, with higher density in DE and SUP in comparison to OMA).</p><p><strong>Conclusion: </strong>A standardized protocol is presented to measure PGP9.5 nerve bundle density in endometriosis, which may serve as a biomarker reflecting local neurogenesis in the endometriosis microenvironment.</p>","PeriodicalId":73103,"journal":{"name":"Frontiers in reproductive health","volume":"5 ","pages":"1297986"},"PeriodicalIF":0.0,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10720898/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138814583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fertility after expanded polytetrafluoroethylene use after endometrioma cystectomy: a pilot study. 子宫内膜瘤膀胱切除术后使用膨体聚四氟乙烯后的生育能力:一项试点研究。
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-22 eCollection Date: 2023-01-01 DOI: 10.3389/frph.2023.1231029
Patrick P Yeung, Melody S Su, John Voltz, Jeffrey A Gavard

Introduction: Pregnancy rates after the placement of expanded polytetrafluoroethylene (ePTFE, trade name Gore-Tex®) for adhesion prevention following cystectomy of endometriomas ≥3 cm and excision of endometriosis were analyzed in this pilot study.

Methods: A prospective cohort study was performed at a single tertiary care center. 56 women qualified for the study and underwent surgery. Expanded polytetrafluoroethylene placement around affected ovaries was self-selected. Inclusion criteria for analysis were pathology-confirmed endometrioma ≥3 cm, no hysterectomy at time of surgery, ≥1 year of postoperative survey completion, and absence of strategies to avoid pregnancy. 18 women in the ePTFE group and 11 women in the control group met inclusion criteria for analysis. 16 of the 18 women in the ePTFE group and 7 of the 11 women in the control group were affected by infertility. Absolute pregnancy rates and cumulative 4-year pregnancy rates, which are based on survival analysis using lifetables and adjust for varying follow-up times, were calculated for all women as well as for women with infertility only.

Results: High cumulative 4-year pregnancy rates were observed for women with expanded polytetrafluoroethylene compared to women without (85% vs. 65%, p = 0.69). High cumulative 4-year pregnancy rates for women with infertility prior to surgery were observed for women with expanded polytetrafluoroethylene compared to women without (83% vs. 33%, p = 0.89).

Discussion: There are consistent trends, although not statistically significant, seen in pregnancy rates for women with ePTFE compared to women without, particularly in those with a history of infertility prior to ePTFE use. This is the first study examining how adhesion prevention strategy targeting the adnexa during surgery for endometriosis affects pregnancy rates. The trend towards increased pregnancy rates with expanded polytetrafluoroethylene use, particularly in patients with a history of infertility, is promising and warrants further study with larger groups.

简介:本试验性研究分析了子宫内膜异位症≥3厘米的膀胱切除术和子宫内膜异位症切除术后为防止粘连而置入膨体聚四氟乙烯(ePTFE,商品名Gore-Tex®)后的妊娠率:方法:在一家三级医疗中心进行了一项前瞻性队列研究。56名妇女符合研究条件并接受了手术。受影响卵巢周围的膨体聚四氟乙烯置入术由患者自行选择。纳入分析的标准是病理证实子宫内膜异位症≥3厘米、手术时未切除子宫、术后调查完成时间≥1年、未采取避孕措施。符合纳入分析标准的 ePTFE 组妇女有 18 人,对照组妇女有 11 人。ePTFE 组的 18 位女性中有 16 位不孕,对照组的 11 位女性中有 7 位不孕。通过使用生命表进行生存分析,并根据不同的随访时间进行调整,计算了所有女性和仅有不孕症女性的绝对妊娠率和4年累积妊娠率:结果:与未使用膨体聚四氟乙烯的妇女相比,使用膨体聚四氟乙烯的妇女的 4 年累积怀孕率较高(85% 对 65%,P = 0.69)。与未使用膨体聚四氟乙烯的妇女相比,使用膨体聚四氟乙烯的妇女术前不孕的4年累积妊娠率较高(83% vs. 33%,p = 0.89):讨论:与未使用膨体聚四氟乙烯的女性相比,使用膨体聚四氟乙烯的女性的妊娠率有一致的趋势,尤其是在使用膨体聚四氟乙烯前有不孕史的女性中,尽管没有统计学意义。这是第一项针对子宫内膜异位症手术中针对附件的粘连预防策略如何影响妊娠率的研究。使用膨体聚四氟乙烯后,怀孕率呈上升趋势,尤其是在有不孕史的患者中,这种趋势很有希望,值得在更大的群体中进行进一步研究。
{"title":"Fertility after expanded polytetrafluoroethylene use after endometrioma cystectomy: a pilot study.","authors":"Patrick P Yeung, Melody S Su, John Voltz, Jeffrey A Gavard","doi":"10.3389/frph.2023.1231029","DOIUrl":"https://doi.org/10.3389/frph.2023.1231029","url":null,"abstract":"<p><strong>Introduction: </strong>Pregnancy rates after the placement of expanded polytetrafluoroethylene (ePTFE, trade name Gore-Tex®) for adhesion prevention following cystectomy of endometriomas ≥3 cm and excision of endometriosis were analyzed in this pilot study.</p><p><strong>Methods: </strong>A prospective cohort study was performed at a single tertiary care center. 56 women qualified for the study and underwent surgery. Expanded polytetrafluoroethylene placement around affected ovaries was self-selected. Inclusion criteria for analysis were pathology-confirmed endometrioma ≥3 cm, no hysterectomy at time of surgery, ≥1 year of postoperative survey completion, and absence of strategies to avoid pregnancy. 18 women in the ePTFE group and 11 women in the control group met inclusion criteria for analysis. 16 of the 18 women in the ePTFE group and 7 of the 11 women in the control group were affected by infertility. Absolute pregnancy rates and cumulative 4-year pregnancy rates, which are based on survival analysis using lifetables and adjust for varying follow-up times, were calculated for all women as well as for women with infertility only.</p><p><strong>Results: </strong>High cumulative 4-year pregnancy rates were observed for women with expanded polytetrafluoroethylene compared to women without (85% vs. 65%, p = 0.69). High cumulative 4-year pregnancy rates for women with infertility prior to surgery were observed for women with expanded polytetrafluoroethylene compared to women without (83% vs. 33%, p = 0.89).</p><p><strong>Discussion: </strong>There are consistent trends, although not statistically significant, seen in pregnancy rates for women with ePTFE compared to women without, particularly in those with a history of infertility prior to ePTFE use. This is the first study examining how adhesion prevention strategy targeting the adnexa during surgery for endometriosis affects pregnancy rates. The trend towards increased pregnancy rates with expanded polytetrafluoroethylene use, particularly in patients with a history of infertility, is promising and warrants further study with larger groups.</p>","PeriodicalId":73103,"journal":{"name":"Frontiers in reproductive health","volume":"5 ","pages":"1231029"},"PeriodicalIF":0.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10703387/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138814580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum: Editorial: Period poverty. 更正:社论:贫困时期。
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-20 eCollection Date: 2023-01-01 DOI: 10.3389/frph.2023.1308137
Lea Sacca, Christine Margaret Markham, Jhumka Gupta, Melissa Peskin

[This corrects the article DOI: 10.3389/frph.2023.1140981.].

[此处更正了文章 DOI:10.3389/frph.2023.1140981]。
{"title":"Corrigendum: Editorial: Period poverty.","authors":"Lea Sacca, Christine Margaret Markham, Jhumka Gupta, Melissa Peskin","doi":"10.3389/frph.2023.1308137","DOIUrl":"https://doi.org/10.3389/frph.2023.1308137","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/frph.2023.1140981.].</p>","PeriodicalId":73103,"journal":{"name":"Frontiers in reproductive health","volume":"5 ","pages":"1308137"},"PeriodicalIF":0.0,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694433/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138489280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An implementation strategy package (video education, HIV self-testing, and co-location) improves PrEP implementation for pregnant women in antenatal care clinics in western Kenya. 一揽子实施战略(视频教育、艾滋病毒自我检测和合址)改善了肯尼亚西部产前保健诊所孕妇的PrEP实施情况。
IF 2.3 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-17 eCollection Date: 2023-01-01 DOI: 10.3389/frph.2023.1205503
Joseph Sila, Anjuli D Wagner, Felix Abuna, Julia C Dettinger, Ben Odhiambo, Nancy Ngumbau, George Oketch, Enock Sifuna, Laurén Gómez, Sarah Hicks, Grace John-Stewart, John Kinuthia
<p><strong>Background: </strong>Pre-exposure prophylaxis (PrEP) is recommended by the World Health Organization and the Kenyan Ministry of Health for HIV prevention in pregnancy and postpartum for women at risk for HIV. Integration of PrEP into antenatal care is promising, but delivery gaps exist in the face of healthcare provider shortages in resource-limited settings.</p><p><strong>Methods: </strong>Between May and November 2021, we conducted a difference-in-differences study (3 months pre-intervention data collection and 3 months post-intervention data collection) analyzing four intervention facilities, where the strategies were implemented, and four comparison facilities, where no strategies were implemented. We tested a combination of three implementation strategies-video-based PrEP information in the waiting bay, HIV self-testing, and dispensing of PrEP in the antenatal care rooms-to improve PrEP delivery. We compared absolute changes in the proportion of antenatal attendees screened for PrEP (PrEP penetration), the proportion receiving all PrEP-specific steps in a visit (HIV testing, risk screening, and PrEP counseling) (PrEP fidelity), and client PrEP knowledge, client satisfaction, and waiting time and service time (<i>a priori</i> outcomes); <i>post hoc,</i> we compared the proportion offered PrEP (PrEP offer) and completing HIV testing. We measured provider perceptions of the acceptability and appropriateness of the implementation strategies.</p><p><strong>Results: </strong>We observed significant improvements in PrEP penetration, PrEP offer, satisfaction, and knowledge (<i>p</i> < 0.05) and improvements in fidelity that trended towards significance (<i>p</i> = 0.057). PrEP penetration increased 5 percentage points (<i>p</i> = 0.008), PrEP fidelity increased 8 percentage points (<i>p</i> = 0.057), and PrEP offer increased 4 percentage points (<i>p</i> = 0.003) in intervention vs. comparison facilities. Client PrEP knowledge increased by 1.7 out of 6 total points (<i>p</i> < 0.001) and client satisfaction increased by 0.7 out of 24 total points (<i>p</i> = 0.003) in intervention vs. comparison facilities. We observed no changes in service time (0.09-min decrease; <i>p</i> = 0.435) and a small increase in waiting time (0.33-min increase; <i>p</i> = 0.005). HIV testing among those eligible did not change (1.5 percentage point decrease, <i>p</i> = 0.800). Providers felt the implementation strategies were acceptable and appropriate (median acceptability: 20/20; median appropriateness: 19.5/20). However, absolute levels of each step of the PrEP cascade remained suboptimal.</p><p><strong>Conclusions: </strong>An implementation strategy package with video information, HIV self-testing, and co-location of medication dispensing enhanced PrEP delivery across several implementation outcomes and client satisfaction, while not substantially increasing wait time or decreasing provider-client contact time.</p><p><strong>Clinical trial registration: </
背景:暴露前预防(PrEP)是世界卫生组织和肯尼亚卫生部推荐的用于艾滋病毒感染风险妇女在怀孕和产后预防艾滋病毒的方法。将PrEP纳入产前保健是有希望的,但在资源有限的情况下,面对卫生保健提供者短缺,存在交付差距。方法:在2021年5月至11月期间,我们进行了一项差异中的差异研究(3个月的干预前数据收集和3个月的干预后数据收集),分析了四个实施了策略的干预设施和四个未实施策略的比较设施。我们测试了三种实施策略的组合-在候诊室提供基于视频的PrEP信息,艾滋病毒自我检测和在产前护理室分发PrEP -以改善PrEP的提供。我们比较了产前参与者接受PrEP筛查的比例(PrEP渗透率)、在一次就诊中接受所有PrEP特定步骤(HIV检测、风险筛查和PrEP咨询)的比例(PrEP保真度)、客户PrEP知识、客户满意度、等待时间和服务时间(先验结果)的绝对变化;事后,我们比较了提供PrEP (PrEP offer)和完成HIV检测的比例。我们测量了提供者对实现策略的可接受性和适当性的看法。结果:我们观察到PrEP普及率,PrEP提供,满意度和知识显著提高(p p = 0.057)。与对照设施相比,干预设施的PrEP普及率提高了5个百分点(p = 0.008), PrEP保真度提高了8个百分点(p = 0.057), PrEP提供率提高了4个百分点(p = 0.003)。与比较机构相比,干预机构的客户PrEP知识增加了1.7分(总分6分)(p p = 0.003)。我们观察到服务时间没有变化(减少0.09 min;P = 0.435),等待时间略有增加(增加0.33 min;p = 0.005)。符合条件的艾滋病病毒检测没有变化(降低1.5个百分点,p = 0.800)。提供者认为实施策略是可接受和适当的(可接受度中位数:20/20;适当性中位数:19.5/20)。然而,PrEP级联的每个步骤的绝对水平仍然不是最佳的。结论:包含视频信息、艾滋病毒自检和配药地点的实施策略包在几个实施结果和客户满意度方面增强了PrEP的提供,同时没有显著增加等待时间或减少提供者与客户的接触时间。临床试验注册:ClinicalTrials.gov,识别码:NCT04712994。
{"title":"An implementation strategy package (video education, HIV self-testing, and co-location) improves PrEP implementation for pregnant women in antenatal care clinics in western Kenya.","authors":"Joseph Sila, Anjuli D Wagner, Felix Abuna, Julia C Dettinger, Ben Odhiambo, Nancy Ngumbau, George Oketch, Enock Sifuna, Laurén Gómez, Sarah Hicks, Grace John-Stewart, John Kinuthia","doi":"10.3389/frph.2023.1205503","DOIUrl":"10.3389/frph.2023.1205503","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Pre-exposure prophylaxis (PrEP) is recommended by the World Health Organization and the Kenyan Ministry of Health for HIV prevention in pregnancy and postpartum for women at risk for HIV. Integration of PrEP into antenatal care is promising, but delivery gaps exist in the face of healthcare provider shortages in resource-limited settings.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Between May and November 2021, we conducted a difference-in-differences study (3 months pre-intervention data collection and 3 months post-intervention data collection) analyzing four intervention facilities, where the strategies were implemented, and four comparison facilities, where no strategies were implemented. We tested a combination of three implementation strategies-video-based PrEP information in the waiting bay, HIV self-testing, and dispensing of PrEP in the antenatal care rooms-to improve PrEP delivery. We compared absolute changes in the proportion of antenatal attendees screened for PrEP (PrEP penetration), the proportion receiving all PrEP-specific steps in a visit (HIV testing, risk screening, and PrEP counseling) (PrEP fidelity), and client PrEP knowledge, client satisfaction, and waiting time and service time (&lt;i&gt;a priori&lt;/i&gt; outcomes); &lt;i&gt;post hoc,&lt;/i&gt; we compared the proportion offered PrEP (PrEP offer) and completing HIV testing. We measured provider perceptions of the acceptability and appropriateness of the implementation strategies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We observed significant improvements in PrEP penetration, PrEP offer, satisfaction, and knowledge (&lt;i&gt;p&lt;/i&gt; &lt; 0.05) and improvements in fidelity that trended towards significance (&lt;i&gt;p&lt;/i&gt; = 0.057). PrEP penetration increased 5 percentage points (&lt;i&gt;p&lt;/i&gt; = 0.008), PrEP fidelity increased 8 percentage points (&lt;i&gt;p&lt;/i&gt; = 0.057), and PrEP offer increased 4 percentage points (&lt;i&gt;p&lt;/i&gt; = 0.003) in intervention vs. comparison facilities. Client PrEP knowledge increased by 1.7 out of 6 total points (&lt;i&gt;p&lt;/i&gt; &lt; 0.001) and client satisfaction increased by 0.7 out of 24 total points (&lt;i&gt;p&lt;/i&gt; = 0.003) in intervention vs. comparison facilities. We observed no changes in service time (0.09-min decrease; &lt;i&gt;p&lt;/i&gt; = 0.435) and a small increase in waiting time (0.33-min increase; &lt;i&gt;p&lt;/i&gt; = 0.005). HIV testing among those eligible did not change (1.5 percentage point decrease, &lt;i&gt;p&lt;/i&gt; = 0.800). Providers felt the implementation strategies were acceptable and appropriate (median acceptability: 20/20; median appropriateness: 19.5/20). However, absolute levels of each step of the PrEP cascade remained suboptimal.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;An implementation strategy package with video information, HIV self-testing, and co-location of medication dispensing enhanced PrEP delivery across several implementation outcomes and client satisfaction, while not substantially increasing wait time or decreasing provider-client contact time.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical trial registration: &lt;/","PeriodicalId":73103,"journal":{"name":"Frontiers in reproductive health","volume":"5 ","pages":"1205503"},"PeriodicalIF":2.3,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138479671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contraceptive use and discontinuation among women aged 15-24 years in Kenya. 肯尼亚15-24岁妇女避孕药具的使用和停止。
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-15 eCollection Date: 2023-01-01 DOI: 10.3389/frph.2023.1192193
Wambui Kungu

Introduction: The 15-24-year-old age group of young women make up about 15% of the population of 47 million Kenyans which comes to 7 million. Addressing the reproductive health goals of this cohort is thus a policy priority because of the high potential they pose for unintended pregnancy through incorrect and intermittent use of contraception.

Objective: The study sought to present evidence on contraceptive use among women aged 15-24 in Kenya between 2012 and 2014 using Kenya Demographic and Health Survey (KDHS) 2014 Contraceptive calendar data and make recommendations on enhancing the correct and consistent use of contraception.

Methodology: The data used was obtained from the Choices and Challenges tool developed by Population Reference Bureau (PRB) and visualized innovatively using Sankey Diagrams that show contraceptive use/non-use, continuation, switching/discontinuation, and pregnancy.

Results: The use of contraceptives went up by about 30% during the study period while the use of modern methods went up by 83%. The uptake of Long-Acting Reversible Contraception (LARC) went up by 87% while that of Short Acting Methods (SAM) went up by 70% but the progress was clouded by discontinuation rates of 35% with side effects being the leading reason for the abandonment of contraception.

Conclusion: For Kenya to achieve transformative results in ending the unmet need for contraception and preventable maternal deaths, it is critical to sustaining the current gains in contraceptive prevalence rate (CPR) by promoting the retention of youth users and encouraging new users.

简介:15-24岁年龄组的年轻女性约占肯尼亚4700万人口的15%,达到700万。因此,解决这一群体的生殖健康目标是一项政策优先事项,因为他们通过不正确和间歇性使用避孕措施造成意外怀孕的可能性很大。目的:本研究旨在利用肯尼亚人口与健康调查(KDHS) 2014年避孕日历数据,提供2012年至2014年肯尼亚15-24岁妇女避孕药具使用情况的证据,并就加强正确和一致地使用避孕药具提出建议。方法:使用的数据来自人口参考局(PRB)开发的“选择与挑战”工具,并使用桑基图进行创新性可视化,显示避孕使用/不使用、继续使用、切换/停止使用和怀孕情况。结果:在研究期间,避孕药具的使用率上升了约30%,而现代避孕方法的使用率上升了83%。长效可逆避孕(LARC)的使用率上升了87%,而短效避孕(SAM)的使用率上升了70%,但停药率为35%,副作用是放弃避孕的主要原因,这一进展受到影响。结论:肯尼亚要在结束未满足的避孕需求和可预防的孕产妇死亡方面取得变革性成果,就必须通过促进青年用户的留存和鼓励新用户来维持目前在避孕普及率方面取得的进展。
{"title":"Contraceptive use and discontinuation among women aged 15-24 years in Kenya.","authors":"Wambui Kungu","doi":"10.3389/frph.2023.1192193","DOIUrl":"10.3389/frph.2023.1192193","url":null,"abstract":"<p><strong>Introduction: </strong>The 15-24-year-old age group of young women make up about 15% of the population of 47 million Kenyans which comes to 7 million. Addressing the reproductive health goals of this cohort is thus a policy priority because of the high potential they pose for unintended pregnancy through incorrect and intermittent use of contraception.</p><p><strong>Objective: </strong>The study sought to present evidence on contraceptive use among women aged 15-24 in Kenya between 2012 and 2014 using Kenya Demographic and Health Survey (KDHS) 2014 Contraceptive calendar data and make recommendations on enhancing the correct and consistent use of contraception.</p><p><strong>Methodology: </strong>The data used was obtained from the Choices and Challenges tool developed by Population Reference Bureau (PRB) and visualized innovatively using Sankey Diagrams that show contraceptive use/non-use, continuation, switching/discontinuation, and pregnancy.</p><p><strong>Results: </strong>The use of contraceptives went up by about 30% during the study period while the use of modern methods went up by 83%. The uptake of Long-Acting Reversible Contraception (LARC) went up by 87% while that of Short Acting Methods (SAM) went up by 70% but the progress was clouded by discontinuation rates of 35% with side effects being the leading reason for the abandonment of contraception.</p><p><strong>Conclusion: </strong>For Kenya to achieve transformative results in ending the unmet need for contraception and preventable maternal deaths, it is critical to sustaining the current gains in contraceptive prevalence rate (CPR) by promoting the retention of youth users and encouraging new users.</p>","PeriodicalId":73103,"journal":{"name":"Frontiers in reproductive health","volume":"5 ","pages":"1192193"},"PeriodicalIF":0.0,"publicationDate":"2023-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138464777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficient regulatory approval of two novel HIV prevention interventions in a resource-limited setting: experiences from Zimbabwe 在资源有限的环境中有效地批准两种新的艾滋病毒预防干预措施:来自津巴布韦的经验
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-14 DOI: 10.3389/frph.2023.1279124
Caroline Murombedzi, Libert Chirinda, Gift T. Chareka, Z. Mike Chirenje, Nyaradzo M. Mgodi
The global burden of HIV remains unacceptably high despite significant progress made in HIV treatment and prevention. There is an urgent need to scale up the comprehensive HIV prevention strategies that include pre-exposure prophylaxis (PrEP). Oral PrEP is highly effective in preventing HIV acquisition when taken regularly, but this remains a challenge for some at-risk individuals. Therefore, there is a need for other HIV prevention options. The dapivirine vaginal ring (DVR) and long-acting injectable cabotegravir (CAB-LA) are novel biomedical interventions that are safe and efficacious for HIV pre-exposure prophylaxis, as demonstrated in recently completed clinical trials. Timely roll-out and scalability of efficacious interventions depend on the registration process with the national medicine regulatory authorities (NMRAs). The Medicines Control Authority of Zimbabwe (MCAZ) was the first NMRA globally to approve the DVR in July 2021 and the first in Africa to approve CAB-LA for HIV prevention in July 2022. The regulatory review process for DVR and CAB-LA by MCAZ took 4.5 and 5.5 months, respectively. This efficient review process of the two interventions by MCAZ, a regulatory body in a resource-limited setting, provides important lessons to shorten timelines between the completion of the clinical development process and the registration of essential medicines.
尽管在艾滋病毒治疗和预防方面取得了重大进展,但艾滋病毒的全球负担仍然高得令人无法接受。迫切需要扩大包括暴露前预防(PrEP)在内的全面艾滋病毒预防战略。如果定期服用口服PrEP,在预防感染艾滋病毒方面非常有效,但这对一些高危人群来说仍然是一个挑战。因此,有必要采取其他艾滋病毒预防措施。最近完成的临床试验表明,达匹维林阴道环(DVR)和长效注射卡博特重力韦(CAB-LA)是一种安全有效的新型生物医学干预措施,可用于艾滋病毒暴露前预防。有效干预措施的及时推出和可扩展性取决于国家药品监管机构(NMRAs)的注册程序。津巴布韦药品管理局(MCAZ)是全球第一个于2021年7月批准DVR的国家药品管理局,也是非洲第一个于2022年7月批准CAB-LA用于艾滋病毒预防的国家药品管理局。MCAZ对DVR和CAB-LA的监管审查过程分别耗时4.5个月和5.5个月。MCAZ是一个资源有限的监管机构,它对这两种干预措施进行了有效的审查,为缩短完成临床开发过程和基本药物注册之间的时间间隔提供了重要经验。
{"title":"Efficient regulatory approval of two novel HIV prevention interventions in a resource-limited setting: experiences from Zimbabwe","authors":"Caroline Murombedzi, Libert Chirinda, Gift T. Chareka, Z. Mike Chirenje, Nyaradzo M. Mgodi","doi":"10.3389/frph.2023.1279124","DOIUrl":"https://doi.org/10.3389/frph.2023.1279124","url":null,"abstract":"The global burden of HIV remains unacceptably high despite significant progress made in HIV treatment and prevention. There is an urgent need to scale up the comprehensive HIV prevention strategies that include pre-exposure prophylaxis (PrEP). Oral PrEP is highly effective in preventing HIV acquisition when taken regularly, but this remains a challenge for some at-risk individuals. Therefore, there is a need for other HIV prevention options. The dapivirine vaginal ring (DVR) and long-acting injectable cabotegravir (CAB-LA) are novel biomedical interventions that are safe and efficacious for HIV pre-exposure prophylaxis, as demonstrated in recently completed clinical trials. Timely roll-out and scalability of efficacious interventions depend on the registration process with the national medicine regulatory authorities (NMRAs). The Medicines Control Authority of Zimbabwe (MCAZ) was the first NMRA globally to approve the DVR in July 2021 and the first in Africa to approve CAB-LA for HIV prevention in July 2022. The regulatory review process for DVR and CAB-LA by MCAZ took 4.5 and 5.5 months, respectively. This efficient review process of the two interventions by MCAZ, a regulatory body in a resource-limited setting, provides important lessons to shorten timelines between the completion of the clinical development process and the registration of essential medicines.","PeriodicalId":73103,"journal":{"name":"Frontiers in reproductive health","volume":"41 43","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134954602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Common ground: the opportunity of male contraceptives as MPTs 共同点:男性避孕药作为mpt的机会
Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-11-10 DOI: 10.3389/frph.2023.1278709
Heather L. Vahdat, Logan M. Nickels
Multipurpose prevention technologies (MPTs) and male contraceptive methods are currently in development to address unique and critical needs facing the global reproductive health community. Currently, MPT products in development are exclusively female-focused due to the readily available nature and regulatory precedent offered by female contraceptive active pharmaceutical ingredients (APIs); however, the opportunity to explore codevelopment with male contraceptive methods, which are at a comparatively early stage of development, should not be overlooked. These fields face parallel challenges including research and development, commercialization, regulatory approval, and market uptake, and these parallels can inform strategic alignment between the fields. One challenge that precludes codevelopment, however, is the path to market and associated funding models for these innovative, yet underappreciated fields. Without candid review, reconsideration, prioritization, and innovation led by the donor and investment communities, product developers will have no compelling reason to consider accepting the added regulatory and fiscal burden associated with combining development streams.
目前正在开发多用途预防技术和男性避孕方法,以解决全球生殖卫生界面临的独特和关键需求。目前,由于女性避孕活性药物成分(api)的易得性和监管先例,正在开发的MPT产品专门针对女性;然而,不应忽视探索与处于相对早期发展阶段的男性避孕方法共同发展的机会。这些领域面临着类似的挑战,包括研发、商业化、监管审批和市场吸收,这些相似之处可以为领域之间的战略调整提供信息。然而,阻碍共同开发的一个挑战是这些创新但未得到充分重视的领域的市场路径和相关的融资模式。如果没有捐助者和投资界领导的坦率的审查、重新考虑、优先排序和创新,产品开发人员将没有令人信服的理由考虑接受与合并开发流相关的额外监管和财政负担。
{"title":"Common ground: the opportunity of male contraceptives as MPTs","authors":"Heather L. Vahdat, Logan M. Nickels","doi":"10.3389/frph.2023.1278709","DOIUrl":"https://doi.org/10.3389/frph.2023.1278709","url":null,"abstract":"Multipurpose prevention technologies (MPTs) and male contraceptive methods are currently in development to address unique and critical needs facing the global reproductive health community. Currently, MPT products in development are exclusively female-focused due to the readily available nature and regulatory precedent offered by female contraceptive active pharmaceutical ingredients (APIs); however, the opportunity to explore codevelopment with male contraceptive methods, which are at a comparatively early stage of development, should not be overlooked. These fields face parallel challenges including research and development, commercialization, regulatory approval, and market uptake, and these parallels can inform strategic alignment between the fields. One challenge that precludes codevelopment, however, is the path to market and associated funding models for these innovative, yet underappreciated fields. Without candid review, reconsideration, prioritization, and innovation led by the donor and investment communities, product developers will have no compelling reason to consider accepting the added regulatory and fiscal burden associated with combining development streams.","PeriodicalId":73103,"journal":{"name":"Frontiers in reproductive health","volume":" 8","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135191149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in reproductive health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1